Devises / TAK
TAK: Takeda Pharmaceutical Company Limited American Depositary Share
14.16
USD
0.06
(0.43%)
Le taux de change de TAK a changé de 0.43% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 14.06 et à un maximum de 14.23.
Suivez la dynamique Takeda Pharmaceutical Company Limited American Depositary Share. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TAK Nouvelles
- Investing Takeda Pharma ADR earnings beat by $150.82, revenue fell short of estimates
- Benzinga Why Is Takeda Pharma Stock Falling On Wednesday? - Takeda Pharmaceutical Co (NYSE:TAK)
- Investor's Business Daily Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
- Seeking Alpha Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK)
- Seeking Alpha Astria: Betting On Navenibart In The Crowded HAE Arena
- Investing Takeda stock rises after positive Phase 3 results for narcolepsy drug
- Seeking Alpha Takeda: Positives And Negatives Offset Each Other (NYSE:TAK)
- Investing US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
- Seeking Alpha Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE)
- Seeking Alpha Amgen Stock: Imdelltra Data And Q1 Results Impress (NASDAQ:AMGN)
- Seeking Alpha ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
- Investing Jefferies raises Veeva Systems stock price target to $335 from $280
- Investing TD Cowen lifts Veeva stock price target to $284 on strong F1Q results
- Investing Truist lifts Veeva Systems stock target to $230, keeps Hold rating
- Investing Takeda files executive compensation report with SEC
- Investing Takeda schedules annual shareholder meeting
- Investing TD Cowen maintains Buy on Takeda, reiterates $16 target
- Investor's Business Daily S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'
- Benzinga Takeda Expects Limited Exposure To US-China Tariffs - Takeda Pharmaceutical Co (NYSE:TAK)
- Seeking Alpha Johnson & Johnson Stock Just Proved The Bears Wrong Again (NYSE:JNJ)
- Seeking Alpha Keros Therapeutics (KROS): Strategic Alternatives Could Bring About Value Creation
- Seeking Alpha Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
- Seeking Alpha Phathom Pharmaceuticals: The Clock Is Ticking On Voquezna (Downgrade) (PHAT)
- Benzinga UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients - Pfizer (NYSE:PFE)
Range quotidien
14.06
14.23
Range Annuel
12.80
15.53
- Clôture Précédente
- 13.72
- Ouverture
- 14.10
- Bid
- 14.16
- Ask
- 14.46
- Plus Bas
- 14.06
- Plus Haut
- 14.23
- Volume
- 8.491 K
- Changement quotidien
- 0.43%
- Changement Mensuel
- 0.43%
- Changement à 6 Mois
- -2.88%
- Changement Annuel
- -4.84%
03 août, dimanche